Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vinay

Showing results (111-120 of 14,057) with videos related to

Pageof 1,406
Sort By:
Nature Reviews. Clinical Oncology|October 5, 2017
Immunotherapy: Tisagenlecleucel - the first approved CAR-T-cell therapy: implications for payers and policy makersVinay Prasad
BMJ (Clinical Research Ed.)|October 6, 2017
Do cancer drugs improve survival or quality of life?Vinay Prasad
Journal of the National Comprehensive Cancer Network : JNCCN|March 10, 2016
How Should Research Be Funded? Difficulties With the Argument for Proportionality to Causes of Death or Years of Life LostVinay Prasad
Indian Journal of Medical Ethics|October 21, 2009
From judgement to practice: Section 377 and the medical sectorVinay Chandran
JAMA Pediatrics|August 4, 2018
Inconsistent Reporting of Potential Conflicts of InterestVinay Prasad
Nature|September 8, 2016
Perspective: The precision-oncology illusionVinay Prasad
Annals of Internal Medicine|June 18, 2014
Statins, primary prevention, and overall mortalityVinay Prasad
Journal of Clinical and Experimental Hepatology|March 11, 2015
Role of liver transplantation for hepatocellular carcinomaVinay Kumaran
Gastrointestinal Endoscopy|January 25, 2015
Thinking inside the box: 3-dimensional printing for interventional EUS trainingVinay Chandrasekhara
Oncotarget|July 6, 2015
Catalytically inactive telomerase in oncogenesisVinay Tergaonkar
Pageof 1,406

Showing results (111-120 of 14,057) with videos related to

Sort By:
Pageof 1,406
Nature Reviews. Clinical Oncology|October 5, 2017
Immunotherapy: Tisagenlecleucel - the first approved CAR-T-cell therapy: implications for payers and policy makersVinay Prasad
BMJ (Clinical Research Ed.)|October 6, 2017
Do cancer drugs improve survival or quality of life?Vinay Prasad
Journal of the National Comprehensive Cancer Network : JNCCN|March 10, 2016
How Should Research Be Funded? Difficulties With the Argument for Proportionality to Causes of Death or Years of Life LostVinay Prasad
Indian Journal of Medical Ethics|October 21, 2009
From judgement to practice: Section 377 and the medical sectorVinay Chandran
JAMA Pediatrics|August 4, 2018
Inconsistent Reporting of Potential Conflicts of InterestVinay Prasad
Nature|September 8, 2016
Perspective: The precision-oncology illusionVinay Prasad
Annals of Internal Medicine|June 18, 2014
Statins, primary prevention, and overall mortalityVinay Prasad
Journal of Clinical and Experimental Hepatology|March 11, 2015
Role of liver transplantation for hepatocellular carcinomaVinay Kumaran
Gastrointestinal Endoscopy|January 25, 2015
Thinking inside the box: 3-dimensional printing for interventional EUS trainingVinay Chandrasekhara
Oncotarget|July 6, 2015
Catalytically inactive telomerase in oncogenesisVinay Tergaonkar
Pageof 1,406